Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020
- Report ID: 978-1-68038-304-1
- Number of Pages: 75
- Format: Electronic (PDF)
- Historical Data: 2012-2014
- Industry: Healthcare
Market Segmentation
- Global Insulin Product Outlook (Market Revenue in USD Million, 2012 - 2020)
- Rapid-acting
- Long-acting
- Premixed
- Premixed analog
- Short-acting
- Intermediate-acting
- Global Antidiabetics Product Outlook (Market Revenue in USD Million, 2012 - 2020)
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT - 2
- Thiazolidinediones
- Antidiabetics Regional Outlook (Market Revenue in USD Million, 2012 - 2020)
- North America
- North America Insulin Market, by Product
- Rapid-acting
- Long-acting
- Premixed
- Premixed analog
- Short-acting
- Intermediate-acting
- North America Antidiabetics Market, by Product
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT - 2
- Thiazolidinediones
- North America Insulin Market, by Product
- Europe
- Europe Insulin Market, by Product
- Rapid-acting
- Long-acting
- Premixed
- Premixed analog
- Short-acting
- Intermediate-acting
- Europe Antidiabetics Market, by Product
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT - 2
- Thiazolidinediones
- Europe Insulin Market, by Product
- Asia Pacific
- Asia Pacific Insulin Market, by Product
- Rapid-acting
- Long-acting
- Premixed
- Premixed analog
- Short-acting
- Intermediate-acting
- Asia Pacific Antidiabetics Market, by Product
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT - 2
- Thiazolidinediones
- Asia Pacific Insulin Market, by Product
- RoW
- RoW Insulin Market, by Product
- Rapid-acting
- Long-acting
- Premixed
- Premixed analog
- Short-acting
- Intermediate-acting
- RoW Antidiabetics Market, by Product
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT - 2
- Thiazolidinediones
- RoW Insulin Market, by Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2012 to 2020
- Market estimates and forecast for product segments up to 2020
- Regional market size and forecast for product segments up to 2020
- Market estimates and forecast for application segments up to 2020
- Regional market size and forecast for application segments up to 2020
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
